316 related articles for article (PubMed ID: 33476933)
1. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
[TBL] [Abstract][Full Text] [Related]
2. Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive p97 Inhibitors for Potential Anticancer Therapy.
Wang F; Li S; Gan T; Stott GM; Flint A; Chou TF
ChemMedChem; 2020 Apr; 15(8):685-694. PubMed ID: 32162487
[TBL] [Abstract][Full Text] [Related]
3. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
[TBL] [Abstract][Full Text] [Related]
5. Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex.
Fang CJ; Gui L; Zhang X; Moen DR; Li K; Frankowski KJ; Lin HJ; Schoenen FJ; Chou TF
ChemMedChem; 2015 Jan; 10(1):52-6. PubMed ID: 25377500
[TBL] [Abstract][Full Text] [Related]
6. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death.
Magnaghi P; D'Alessio R; Valsasina B; Avanzi N; Rizzi S; Asa D; Gasparri F; Cozzi L; Cucchi U; Orrenius C; Polucci P; Ballinari D; Perrera C; Leone A; Cervi G; Casale E; Xiao Y; Wong C; Anderson DJ; Galvani A; Donati D; O'Brien T; Jackson PK; Isacchi A
Nat Chem Biol; 2013 Sep; 9(9):548-56. PubMed ID: 23892893
[TBL] [Abstract][Full Text] [Related]
7. p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.
Her NG; Toth JI; Ma CT; Wei Y; Motamedchaboki K; Sergienko E; Petroski MD
Cell Chem Biol; 2016 Apr; 23(4):517-28. PubMed ID: 27105284
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.
Zhang Y; Xie X; Wang X; Wen T; Zhao C; Liu H; Zhao B; Zhu Y
Bioorg Med Chem; 2021 May; 38():116114. PubMed ID: 33831696
[TBL] [Abstract][Full Text] [Related]
9. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
10. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways.
Chou TF; Brown SJ; Minond D; Nordin BE; Li K; Jones AC; Chase P; Porubsky PR; Stoltz BM; Schoenen FJ; Patricelli MP; Hodder P; Rosen H; Deshaies RJ
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4834-9. PubMed ID: 21383145
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083.
Tang WK; Odzorig T; Jin W; Xia D
Mol Pharmacol; 2019 Mar; 95(3):286-293. PubMed ID: 30591537
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase.
Chou TF; Li K; Frankowski KJ; Schoenen FJ; Deshaies RJ
ChemMedChem; 2013 Feb; 8(2):297-312. PubMed ID: 23316025
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.
Wang X; Bai E; Zhou H; Sha S; Miao H; Qin Y; Liu Z; Wang J; Zhang H; Lei M; Liu J; Hai O; Zhu Y
Bioorg Med Chem; 2019 Feb; 27(3):533-544. PubMed ID: 30606672
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of N - (3 - (1H-imidazol-2-yl) phenyl) - 3-phenylpropionamide derivatives as a novel class of covalent inhibitors of p97/VCP ATPase.
Wang K; Chen L; Dai X; Ye Z; Zhou C; Zhang CJ; Feng Z
Eur J Med Chem; 2023 Feb; 248():115094. PubMed ID: 36634454
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Modulators of the ATPase VCP/p97 Affect Specific p97 Cellular Functions.
Figuerola-Conchas A; Saarbach J; Daguer JP; Cieren A; Barluenga S; Winssinger N; Gotta M
ACS Chem Biol; 2020 Jan; 15(1):243-253. PubMed ID: 31790201
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of p97 by chlorinated analogues of dehydrocurvularin.
Tillotson J; Bashyal BP; Kang M; Shi T; De La Cruz F; Gunatilaka AA; Chapman E
Org Biomol Chem; 2016 Jul; 14(25):5918-21. PubMed ID: 27223265
[TBL] [Abstract][Full Text] [Related]
17. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.
Cervi G; Magnaghi P; Asa D; Avanzi N; Badari A; Borghi D; Caruso M; Cirla A; Cozzi L; Felder E; Galvani A; Gasparri F; Lomolino A; Magnuson S; Malgesini B; Motto I; Pasi M; Rizzi S; Salom B; Sorrentino G; Troiani S; Valsasina B; O'Brien T; Isacchi A; Donati D; D'Alessio R
J Med Chem; 2014 Dec; 57(24):10443-54. PubMed ID: 25474526
[TBL] [Abstract][Full Text] [Related]
19. Development of p97 AAA ATPase inhibitors.
Chou TF; Deshaies RJ
Autophagy; 2011 Sep; 7(9):1091-2. PubMed ID: 21606684
[TBL] [Abstract][Full Text] [Related]
20. Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis.
Anderson DJ; Le Moigne R; Djakovic S; Kumar B; Rice J; Wong S; Wang J; Yao B; Valle E; Kiss von Soly S; Madriaga A; Soriano F; Menon MK; Wu ZY; Kampmann M; Chen Y; Weissman JS; Aftab BT; Yakes FM; Shawver L; Zhou HJ; Wustrow D; Rolfe M
Cancer Cell; 2015 Nov; 28(5):653-665. PubMed ID: 26555175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]